0 items USD 0.00Search
Your search for "qyresearch 2017 2022 lenalidomide report global united states market status forecast players" gave back 48391 results.
The global Lenalidomide market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %...
Catalog:
GIR
January 2024
Price: USD 3,480.00
It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic treatment. Lenalidomide has also...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Lenalidomide, sold under the trade name Revlimid among others, is a medication used to treat multiple myeloma (MM) and myelodysplastic syndromes (MDS...
Catalog:
GIR
April 2023
Price: USD 3,480.00
It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic treatment. Lenalidomide has also...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Lenalidomide, sold under the trade name Revlimid among others, is a medication used to treat multiple myeloma (MM) and myelodysplastic syndromes (MDS...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Lenalidomide, sold under the trade name Revlimid among others, is a medication used to treat multiple myeloma (MM) and myelodysplastic syndromes (MDS...
Catalog:
LPI
January 2023
Price: USD 3,660.00
The global Lenalidomide market size was valued at US$ million in 2023. With growing demand in downstream market, the Lenalidomide is forecast to a...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Summary Lenalidomide market research report provides the newest industry data and industry future trends, allowing you to identify the products and...
Catalog:
ICRW
February 2023
Price: USD 2,960.00
Summary Publisher Lenalidomide market research report provides the newest industry data and industry future trends, allowing you to identify the...
Catalog:
ICRW
May 2021
Price: USD 2,960.00
Summary Lenalidomide market research report provides the newest industry data and industry future trends, allowing you to identify the products and...
Catalog:
ICRW
July 2020
Price: USD 2,960.00
Myelodysplastic (MDS) syndrome is a type of bone marrow disorder, where bone marrow is unable to produce healthy and mature blood cells. The immature...
Catalog:
GIR
January 2023
Price: USD 3,480.00
The “Immunomodulator for Multiple Myeloma Industry Forecast” looks at past sales and reviews total world Immunomodulator for Multiple Myeloma sales...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Highlights The global Myelodysplastic Syndrome (MDS) Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$ million by...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Highlights The global Immunomodulator for Multiple Myeloma market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Myelodysplastic (MDS) syndrome is a type of bone marrow disorder, where bone marrow is unable to produce healthy and mature blood cells. The immature...
Catalog:
LPI
February 2023
Price: USD 3,660.00
